| Name | Title | Contact Details |
|---|
The San Antonio Food Bank is a nonprofit organization focused on fighting hunger and providing hope across Southwest Texas. Established in 1980, it serves a 29-county area, including San Antonio, and assists approximately 100,000 individuals each week, making it one of the largest food banks in Texas. The Food Banks mission includes food distribution, education, and advocacy to combat hunger. It offers emergency food assistance and long-term support programs to help individuals and families achieve self-sufficiency. The organization engages the community through events like Hunger Action Month and the Turkey Trot 5K, raising awareness and funds for its initiatives. Additionally, the Food Bank operates the Mission Farm, cultivating 50 acres of land to produce fresh produce while promoting sustainable farming practices. It partners with over 500 organizations to distribute food and support services to those in need, including families, seniors, and military members.
All Digital Ink is a Chino, CA-based company in the Business Services sector.
i3CG is a Steamboat Springs, CO-based company in the Business Services sector.
Edward Humphrey LLC is a Kenilworth, NJ-based company in the Business Services sector.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.